News & Updates

In the phase III HELIOS-B trial, vutrisiran reduced death and cardiovascular (CV) events in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM).

Use of aspirin appears to be beneficial in the prevention of pancreatic cancer, according to a study.

Nirmatrelvir-ritonavir has emerged as a key antiviral therapy in the fight against COVID-19, particularly for high-risk populations. Two recently published studies demonstrated the efficacy of nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and in those with advanced kidney disease.

Among pregnant women with early gestational diabetes or pre-existing type 2 diabetes (T2D), using metformin in addition to insulin neither lowers the likelihood of preterm pre-eclampsia nor improves serum biomarkers associated with cardiovascular disease risk, according to a study.

For atrial fibrillation (AF) patients with normal or impaired renal function, use of nonvitamin K antagonist oral anticoagulants (NOACs) results in improved outcomes relative to vitamin K antagonist (VKA) therapy, suggests a study presented at ESC 2024.

Postmenopausal women who use menopausal hormone therapy (MHT) appear to have increased Lactobacillus abundance and lower vaginal microbial community diversity, according to a study.

The novel oral corticotropin-releasing factor type 1 receptor antagonist crinecerfont helps supress androstenedione levels in children with congenital adrenal hyperplasia (CAH) and reduce the need for glucocorticoids, as shown in the phase III CAHtalyst Pediatric trial.